Guindo Chirfi 4
4 · Merck & Co., Inc. · Filed Aug 5, 2025
Insider Transaction Report
Form 4
Guindo Chirfi
Chief Marketing Officer
Transactions
- Tax Payment
Common Stock
2025-08-04$79.29/sh−18,175$1,441,096→ 89,233.973 total - Exercise/Conversion
Restricted Stock Unit
2025-08-04−36,903→ 0 totalFrom: 2023-08-03Exp: 2025-08-03→ Common Stock (36,903 underlying) - Exercise/Conversion
Common Stock
2025-08-04$79.29/sh+36,903$2,926,039→ 107,408.973 total
Holdings
- 55.964(indirect: By 401(k))
Common Stock-401(k) Plan
Footnotes (4)
- [F1]Holdings include shares acquired in dividend reinvestment transactions.
- [F2]Includes shares acquired and dividends earned through July 8, 2025 in the Merck U.S. Savings Plan, a 401(k) plan.
- [F3]Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
- [F4]These restricted stock units vested and were distributed as shares of Merck & Co., Inc. common stock in three equal installments on 8/3/2023, 8/3/2024 and 8/3/2025 or, if such date was not a business day, the business day immediately thereafter.